Qiagen, Exosome Diagnostics Expand Partnership to MDx Development | GenomeWeb

NEW YORK (GenomeWeb News) — Qiagen and Exosome Diagnostics said today that they have expanded their collaboration to develop non-invasive in vitro molecular diagnostics.

The diagnostics will be based on Exosome's proprietary methods for purifying nucleic acids from biofluid exosomes and other microvesicles with Qiagen's sample prep technologies to create "cost-effective, easy-to-use, and automated sample-to-results workflows," the companies said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.